BBC Home
Explore the BBC
BBC News
Launch consoleBBC NEWS CHANNEL
Last Updated: Thursday, 10 August 2006, 23:01 GMT 00:01 UK
Glaxo pays $70m to end price row
Tablets generic
The payout settles one case launched by New York in 2003
GlaxoSmithKline has agreed to pay out $70m (36.9m) to settle numerous civil claims of price-fixing in the US.

Several states, health plans and numerous consumers had launched legal action against the group claiming it had inflated the price of some drugs.

The drug maker has admitted no wrongdoing, but said it had made the move to "put the matter behind it".

Glaxo, which earned $2.42bn in the second quarter, said it had already set aside the money for the settlement.


The settlement covers claims by the states of New York, California, Nevada, Connecticut, Montana and Arizona, as well as potential claims in 34 other states and the District of Columbia.

It also resolves a lawsuit filed in Boston by individuals, health care schemes and insurers.

The lawsuits stem from claims that Glaxo used illegal schemes to inflate the price of drugs - including cancer treatments Zofran and Kytril - costing consumers and government health plans hundreds of millions of dollars.

The cases centre on the difference between set rates - or average wholesale prices - that insurance companies and government health plans, such as Medicare and Medicaid, use to reimburse physicians and pharmacies for certain drugs and the amounts the drug companies actually charge.

However, Glaxo's spokeswoman said that the practice was common in the industry.

She added that testimony showed states and health plans chose to use the set price for the drugs although it was "widely known" that this exceeded the price paid by doctors and pharmacies.

New York Attorney General Eliot Spitzer said the agreement - which settles a case he launched in 2003 - would "provide significant restitution for consumers and the Medicaid program".

Glaxo has bird flu 'breakthrough'
26 Jul 06 |  Business
Glaxo 'mulls bid for Pfizer unit'
02 Jun 06 |  Business
Glaxo 'won't be driven out of UK'
17 May 06 |  Business
Glaxo and Astra drug profits soar
27 Apr 06 |  Business
Glaxo agrees US Paxil settlement
29 Mar 06 |  Business

The BBC is not responsible for the content of external internet sites

Has China's housing bubble burst?
How the world's oldest clove tree defied an empire
Why Royal Ballet principal Sergei Polunin quit


Americas Africa Europe Middle East South Asia Asia Pacific